SanBio Company Limited

¥794.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4592Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (5.56%)
Div yield —
ROE (55.86%)
Biotechnology
Beta (5Y) 0.22
PE TTM —
TSR TTM (71.94%)
Mkt cap ¥61.98B
ROIC (30.77%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥899
13.18%
114.97%
Hold 3|8|5|6|3
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
10.29
11.22
11.47
11.16
25.45%
31.62%
21.98%
20.13%
Revenue¥B
5.555
5.470
5.326
5.382
(3.81%)
(3.52%)
(8.66%)
(5.01%)
Peers (US$393.5M)
Cap (US$)
PE
392.5M
—
341.1M
—
240.5M
10.86x
393.9M
203.0x
Capital
TTM
5Y
10Y
Leveragex
0.789
0.202
0.168
EBIT/Intx
1.330
0.226
0.223
Own earn%
(53.80)
18.43
11.68
Sh yield%
19.81
41.89
36.14
Owners
Insiders/Inst%
5.52
40.39
Short interest%
3.43
SBC / revenue%
0.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
1–11
$1 testx
0.0
Incr. ROIC%
6